Old Dominion Capital Management’s TherapeuticsMD TXMD Stock Holding History

Old Dominion Capital Management’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$38K	Hold	1,031	–	–	0.01%	170
2021 Q2	$61K	Hold	1,031	–	–	0.01%	173
2021 Q1	$69K	Hold	1,031	–	–	0.02%	170
2020 Q4	$62K	Hold	1,031	–	–	0.02%	162
2020 Q3	$81K	Hold	1,031	–	–	0.02%	146
2020 Q2	$64K	Hold	1,031	–	–	0.02%	140
2020 Q1	$55K	Hold	1,031	–	–	0.02%	134
2019 Q4	$125K	Buy	+1,031	New	+$148K	0.04%	146
2019 Q3	–	Sell	-1,031	Closed	-$134K	–	148
2019 Q2	$134K	Hold	1,031	–	–	0.05%	134
2019 Q1	$225K	Hold	1,031	–	–	0.08%	130
2018 Q4	$196K	Hold	1,031	–	–	0.07%	138
2018 Q3	$338K	Buy	+1,031	New	+$316K	0.1%	121

Other funds holding TXMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Old Dominion Capital Management's TXMD Position: Q3 2021 in Review

Old Dominion Capital Management held its TherapeuticsMD (TXMD) position steady in Q3 2021 at 1,031 shares worth $38K. The position accounts for 0.01% of the portfolio, ranked #170.

Old Dominion Capital Management first reported a position in TXMD in Q3 2018 and has held it in 12 quarters since. The position peaked at $338K in Q3 2018. 149 funds tracked by Wall St. Rank hold TXMD as of Q3 2021.

Old Dominion Capital Management held 1,031 shares of TherapeuticsMD worth $38K as of Q3 2021.
Old Dominion Capital Management left its TherapeuticsMD share count unchanged in Q3 2021.
TherapeuticsMD made up 0.01% of Old Dominion Capital Management's portfolio in Q3 2021, its #170 holding.
Old Dominion Capital Management first reported a position in TherapeuticsMD in Q3 2018 and has held it in 12 quarters since.
Old Dominion Capital Management's TherapeuticsMD position peaked at $338K in Q3 2018.
149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2021.

Based on Old Dominion Capital Management's 13F filing for Q3 2021, filed 8 Oct 2021.